ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026
Study of association between serum anti-Müllerian hormone, glucose intolerance, and metabolic syndrome in women with polycystic ovarian syndrome: A comparative study.
Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in reproductive-aged women, affecting 5%-10% worldwide. It is a multisystem condition characterized by hyperandrogenism, chronic anovulation, and polycystic ovaries, with potential long-term complications including type 2 diabetes, cardiovascular disease, and metabolic syndrome.
objectiveThis study compares serum anti-Müllerian hormone (AMH) levels between women with and without PCOS and evaluate the prevalence of glucose intolerance and metabolic syndrome in these groups. MATERIALS AND
methodsThis prospective comparative study was conducted on 150 women of reproductive age attending the gynecology outpatient department at Rajarajeshwari Medical College and Hospital, Bengaluru. Group A (n = 75) included women without PCOS, and Group B (n = 75) included women diagnosed with PCOS based on the Rotterdam criteria (2003). Clinical examinations, serum AMH levels, 75 g oral glucose tolerance test, lipid profile, blood pressure, body mass index, waist circumference, and waist-hip ratio were assessed. Data were analyzed to determine associations between AMH, glucose intolerance, and metabolic syndrome.
resultsSerum AMH levels were significantly higher in the PCOS group (mean 7.98 ng/mL), with 63% showing elevated AMH (P < 0.005). Metabolic syndrome was also significantly more common in women with PCOS (P < 0.005). Glucose intolerance was observed in 25% of women with PCOS, but no significant association was observed between serum AMH levels and glucose intolerance in women with PCOS.
conclusionSerum AMH is significantly elevated in women with PCOS and is as a potential marker for predicting metabolic risk but has no association with glucose intolerance in PCOS patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.